Skip to main content
Premium Trial:

Request an Annual Quote

GeneMatrix Garners FDA Emergency Use Authorization for SARS-CoV-2 Test

NEW YORK – The US Food and Drug Administration announced Thursday that South Korean molecular diagnostic firm GeneMatrix received Emergency Use Authorization for its SARS-CoV-2 molecular test. 

The company's NeoPlex COVID-19 Detection Kit uses RT-PCR to detect SARS-CoV-2 nucleic acid from upper and lower respiratory specimens, including nasal swabs, sputum, and tracheal aspirates.

The test can be performed by high-complexity CLIA-certified laboratories.

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.